1. Luzuriaga K, Sullivan JL. Epstein-Barr virus. In : Richman DD, Whitley RJ, Hayden FG, editors. Clinical virology. 3rd ed. Washington, DC: ASM Press;2009. p. 521–536.
2. Evans AS, Niederman JC, Cenabre LC, West B, Richards VA. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody. J Infect Dis. 1975; 132:546–554.
Article
3. Kim JM, Song CW, Song KS, Kim JY. Acute gastritis associated with Epstein-Barr virus infection in a child. Korean J Pediatr. 2016; 59:Suppl 1. S68–S71.
Article
4. Gang MH, Kim JY. Splenic infarction in a child with primary Epstein-Barr virus infection. Pediatr Int. 2013; 55:e126–e128.
Article
5. Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010; 362:1993–2000.
Article
6. Tselis A, Duman R, Storch GA, Lisak RP. Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF. Neurology. 1997; 48:1351–1355.
Article
7. Haller A, von Segesser L, Baumann PC, Krause M. Severe respiratory insufficiency complicating Epstein-Barr virus infection: case report and review. Clin Infect Dis. 1995; 21:206–209.
Article
8. Jenson HB. Epstein-Barr virus. In : Kliegman R, Stanton B, St. Geme J, Schor N, editors. Nelson textbook of pediatrics. 20th ed. Philadelphia: Elsevier;2015. p. 1586–1590.
9. Tynell E, Aurelius E, Brandell A, Julander I, Wood M, Yao QY, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis. 1996; 174:324–331.
Article
10. Hisamatsu A, Nagai T, Okawara H, Nakashima H, Tasaki T, Nakagawa Y, et al. Gastritis associated with Epstein-Barr virus infection. Intern Med. 2010; 49:2101–2105.
Article
11. Zhang Y, Molot R. Severe gastritis secondary to Epstein-Barr viral infection. Unusual presentation of infectious mononucleosis and associated diffuse lymphoid hyperplasia in gastric mucosa. Arch Pathol Lab Med. 2003; 127:478–480.
12. Kitayama Y, Honda S, Sugimura H. Epstein-Barr virus-related gastric pseudolymphoma in infectious mononucleosis. Gastrointest Endosc. 2000; 52:290–291.
Article
13. Jung JK, Chung JP, Kim KC, Park HJ, Lee KS, Chon CY, et al. A case of Epstein-Barr virus-associated primary gastric T-cell lymphoma with rapidly progressive endoscopic features and clinical course. Korean J Gastrointest Endosc. 1999; 19:438–442.
14. Ueo T, Kashima K, Daa T, Kondo Y, Yokoyama S. Coexistence of Epstein-Barr virus-associated gastric carcinoma with malignant lymphoma: report of two cases. Virchows Arch. 2006; 449:215–219.
Article
15. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004; 350:1328–1337.
Article
16. Jaroch MT, Broughan TA, Hermann RE. The natural history of splenic infarction. Surgery. 1986; 100:743–750.
17. Antopolsky M, Hiller N, Salameh S, Goldshtein B, Stalnikowicz R. Splenic infarction: 10 years of experience. Am J Emerg Med. 2009; 27:262–265.
Article
18. García-Carrasco M, Galarza-Maldonado C, Mendoza-Pinto C, Escarcega RO, Cervera R. Infections and the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2009; 36:104–108.
Article
19. Maier W. Computed tomography in the diagnosis of splenic infarction. Eur J Radiol. 1982; 2:202–204.
20. Asgari MM, Begos DG. Spontaneous splenic rupture in infectious mononucleosis: a review. Yale J Biol Med. 1997; 70:175–182.